Menon R - Search Results

1

Venetoclax exposure-efficacy and exposure-safety relationships in patients with treatment-naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.

Brackman D, Eckert D, Menon R, Salem AH, Potluri J, Smith BD, Wei AH, Hayslip J, Miles D, Mensing S, Gopalakrishnan S, Zha J. Brackman D, et al. Among authors: menon r. Hematol Oncol. 2022 Apr;40(2):269-279. doi: 10.1002/hon.2964. Epub 2022 Feb 9. Hematol Oncol. 2022. PMID: 35043428 Free PMC article. Clinical Trial.

2

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir.

Menon RM, Badri PS, Wang T, Polepally AR, Zha J, Khatri A, Wang H, Hu B, Coakley EP, Podsadecki TJ, Awni WM, Dutta S. Menon RM, et al. J Hepatol. 2015 Jul;63(1):20-9. doi: 10.1016/j.jhep.2015.01.026. Epub 2015 Jan 31. J Hepatol. 2015. PMID: 25646891 Free article. Clinical Trial.

3

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir.

Badri PS, Dutta S, Wang H, Podsadecki TJ, Polepally AR, Khatri A, Zha J, Chiu YL, Awni WM, Menon RM. Badri PS, et al. Among authors: menon rm. Antimicrob Agents Chemother. 2015 Oct 12;60(1):105-14. doi: 10.1128/AAC.01778-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26459906 Free PMC article. Clinical Trial.

4

Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects.

Zha J, Badri PS, Ding B, Uchiyama N, Alves K, Rodrigues L Jr, Redman R, Dutta S, Menon RM. Zha J, et al. Among authors: menon rm. Clin Ther. 2015 Nov 1;37(11):2560-71. doi: 10.1016/j.clinthera.2015.09.015. Epub 2015 Oct 23. Clin Ther. 2015. PMID: 26505529

5

Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies.

Mensing S, Polepally AR, König D, Khatri A, Liu W, Podsadecki TJ, Awni WM, Menon RM, Dutta S. Mensing S, et al. Among authors: menon rm. AAPS J. 2016 Jan;18(1):270-80. doi: 10.1208/s12248-015-9846-1. Epub 2015 Nov 23. AAPS J. 2016. PMID: 26597291 Free PMC article.

6

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.

Polepally AR, Mensing S, Khatri A, Beck D, Liu W, Awni WM, Menon RM, Dutta S. Polepally AR, et al. Among authors: menon rm. Clin Pharmacokinet. 2016 Sep;55(9):1091-101. doi: 10.1007/s40262-016-0385-4. Clin Pharmacokinet. 2016. PMID: 27000758 Clinical Trial.

7

Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study.

Gopalakrishnan S, Khatri A, Mensing S, Redman R, Menon R, Zha J. Gopalakrishnan S, et al. Among authors: menon r. Adv Ther. 2016 Apr;33(4):670-83. doi: 10.1007/s12325-016-0320-y. Epub 2016 Mar 21. Adv Ther. 2016. PMID: 27084721 Clinical Trial.

8

Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected Patients.

Khatri A, Mensing S, Podsadecki T, Awni W, Menon R, Dutta S. Khatri A, et al. Among authors: menon r. Clin Drug Investig. 2016 Aug;36(8):625-35. doi: 10.1007/s40261-016-0407-x. Clin Drug Investig. 2016. PMID: 27153823 Clinical Trial.

9

Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection.

Polepally AR, Badri PS, Eckert D, Mensing S, Menon RM. Polepally AR, et al. Among authors: menon rm. Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):333-339. doi: 10.1007/s13318-016-0341-6. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27165046

10

Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.

Gopalakrishnan SM, Polepally AR, Mensing S, Khatri A, Menon RM. Gopalakrishnan SM, et al. Among authors: menon rm. Clin Pharmacokinet. 2017 Jan;56(1):1-10. doi: 10.1007/s40262-016-0423-2. Clin Pharmacokinet. 2017. PMID: 27314261 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,779 results

Search Page